The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication†
Open accessAbstract
Hypermutations in hepatitis B virus (HBV) DNA by APOBEC3 cytidine deaminases have been detected in vitro and in vivo, and APOBEC3G (A3G) and APOBEC3F (A3F) have been shown to inhibit the replication of HBV in vitro, but the presumably low or even absent hepatic expression of these enzymes has raised the question as to their physiological impact on HBV replication. We show that normal human liver expresses the mRNAs of APOBEC3B (A3B), APOBEC3C (A3C), A3F, and A3G. In primary human hepatocytes, interferon alpha (IFN-alpha) stimulated the expression of these cytidine deaminases up to 14-fold, and the mRNAs of A3G, A3F, and A3B reached expression levels of 10%, 3%, and 3%, respectively, relative to GAPDH mRNA abundance. On transfection, the full-length protein A3B(L) inhibited HBV replication in vitro as efficiently as A3G or A3F, whereas the truncated splice variant A3B(S) and A3C had no effect. A3B(L) and A3B(S) were detected predominantly in the nucleus of uninfected cells; however, in HBV-expressing cells both proteins were found also in the cytoplasm and were associated with HBV viral particles, similarly to A3G and A3F. Moreover, A3G, A3F, and A3B(L), but not A3B(S), induced extensive G-to-A hypermutations in a fraction of the replicated HBV genomes. In conclusion, the editing enzymes A3B(L), A3F, and most markedly A3G, which are expressed in liver and up-regulated by IFN-alpha in hepatocytes, are candidates to contribute to the noncytolytic clearance of HBV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells
Chiu, Y.-L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., & Greene, W. C. (2005) · Nature · doi:10.1038/nature03493 · Cited by 439
RetractedHepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,357
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Hepatitis B Virus Immunopathogenesis
Chisari, F. V. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.29 · Cited by 1,609
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
Mangeat, B., Turelli, P., Caron, G., Friedli, M., Perrin, L., & Trono, D. (2003) · Nature · doi:10.1038/nature01709 · Cited by 1,486
Seeger, C., & Mason, W. S. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.51-68.2000 · Cited by 1,451
DNA Deamination Mediates Innate Immunity to Retroviral Infection
Harris, R. S., Bishop, K. N., Sheehy, A. M., Craig, H. M., Petersen-Mahrt, S. K., Watt, I. N., Neuberger, M. S., & Malim, M. H. (2003) · Cell · doi:10.1016/s0092-8674(03)00423-9 · Cited by 1,266
Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex
Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., & Yu, X.-F. (2003) · Science · doi:10.1126/science.1089591 · Cited by 1,200
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
Zhang, H., Yang, B., Pomerantz, R. J., Zhang, C., Arunachalam, S. C., & Gao, L. (2003) · Nature · doi:10.1038/nature01707 · Cited by 1,059
The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
Sheehy, A. M., Gaddis, N. C., & Malim, M. H. (2003) · Nature Medicine · doi:10.1038/nm945 · Cited by 967
HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
Marin, M., Rose, K. M., Kozak, S. L., & Kabat, D. (2003) · Nature Medicine · doi:10.1038/nm946 · Cited by 798
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22
Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., & Navaratnam, N. (2002) · Genomics · doi:10.1006/geno.2002.6718 · Cited by 708
Genomic analysis of the host response to hepatitis B virus infection
Wieland, S., Thimme, R., Purcell, R. H., & Chisari, F. V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401771101 · Cited by 652
Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins
Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S.-J., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 619
Liu, W., & Saint, D. A. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5530 · Cited by 516
Antiviral Function of APOBEC3G Can Be Dissociated from Cytidine Deaminase Activity
Newman, E. N. C., Holmes, R. K., Craig, H. M., Klein, K. C., Lingappa, J. R., Malim, M. H., & Sheehy, A. M. (2005) · Current Biology · doi:10.1016/j.cub.2004.12.068 · Cited by 480
A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins
Wiegand, H. L., Doehle, B. P., Bogerd, H. P., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600246 · Cited by 470
APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo
Liddament, M. T., Brown, W. L., Schumacher, A. J., & Harris, R. S. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.050 · Cited by 440
Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435
Inhibition of Hepatitis B Virus Replication by APOBEC3G
Turelli, P., Mangeat, B., Jost, S., Vianin, S., & Trono, D. (2004) · Science · doi:10.1126/science.1092066 · Cited by 433
Validation of a quantitative method for real time PCR kinetics
Liu, W., & Saint, D. A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00478-3 · Cited by 359
APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses
Esnault, C., Heidmann, O., Delebecque, F., Dewannieux, M., Ribet, D., Hance, A. J., Heidmann, T., & Schwartz, O. (2005) · Nature · doi:10.1038/nature03238 · Cited by 346
Beale, R. C. L., Petersen-Mahrt, S. K., Watt, I. N., Harris, R. S., Rada, C., & Neuberger, M. S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.01.046 · Cited by 339
Complementary function of the two catalytic domains of APOBEC3G
Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., & Landau, N. R. (2005) · Virology · doi:10.1016/j.virol.2005.01.011 · Cited by 305
Suspène, R., Guétard, D., Henry, M., Sommer, P., Wain-Hobson, S., & Vartanian, J.-P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408223102 · Cited by 304
Self-citationAPOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication
Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., & Landau, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408802200 · Cited by 293
Peng, G., Lei, K. J., Jin, W., Greenwell-Wild, T., & Wahl, S. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051512 · Cited by 293
Wieland, S. F., Guidotti, L. G., & Chisari, F. V. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4165-4173.2000 · Cited by 243
Strain, A. J., Ismail, T., Tsubouchi, H., Arakaki, N., Hishida, T., Kitamura, N., Daikuhara, Y., & McMaster, P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115207 · Cited by 197
Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein
Gordien, E., Rosmorduc, O., Peltekian, C., Garreau, F., Bréchot, C., & Kremsdorf, D. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2684-2691.2001 · Cited by 190
Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas
Greeve, J. (2003) · Blood · doi:10.1182/blood-2002-08-2424 · Cited by 177
Self-citationWieland, S. F., Eustaquio, A., Whitten-Bauer, C., Boyd, B., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504273102 · Cited by 168
Nassal, M., & Schaller, H. (1993) · Trends in Microbiology · doi:10.1016/0966-842x(93)90136-f · Cited by 157
APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast
Schumacher, A. J., Nissley, D. V., & Harris, R. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501694102 · Cited by 147
G to A hypermutation of hepatitis B virus†
Noguchi, C., Ishino, H., Tsuge, M., Fujimoto, Y., Imamura, M., Takahashi, S., & Chayama, K. (2005) · Hepatology · doi:10.1002/hep.20580 · Cited by 143
Anti-viral protein APOBEC3G is induced by interferon-α stimulation in human hepatocytes
Tanaka, Y., Marusawa, H., Seno, H., Matsumoto, Y. M., Ueda, Y., Kodama, Y., Endo, Y., Yamauchi, J., Matsumoto, T., Takaori‐Kondo, A., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.192 · Cited by 137
APOBEC‐mediated interference with hepadnavirus production†
Rösler, C., Köck, J., Kann, M., Malim, M. H., Blum, H. E., Baumert, T. F., & von Weizsäcker, F. (2005) · Hepatology · doi:10.1002/hep.20801 · Cited by 135
Inhibition of a Yeast LTR Retrotransposon by Human APOBEC3 Cytidine Deaminases
Dutko, J. A., Schäfer, A., Kenny, A. E., Cullen, B. R., & Curcio, M. J. (2005) · Current Biology · doi:10.1016/j.cub.2005.02.051 · Cited by 134
Suspène, R., Henry, M., Guillot, S., Wain–Hobson, S., & Vartanian, J. (2004) · Journal of General Virology · doi:10.1099/vir.0.80426-0 · Cited by 126
Self-citationWieland, S. F., Vega, R. G., Müller, R., Evans, C. F., Hilbush, B. S., Guidotti, L. G., Sutcliffe, J. G., Schultz, P. G., & Chisari, F. V. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1227-1236.2003 · Cited by 102
Günther, S., Sommer, G., Plikat, U., Iwanska, A., Wain–Hobson, S., Will, H., & Meyerhans, A. (1997) · Virology · doi:10.1006/viro.1997.8676 · Cited by 86
Self-citationComment on "Inhibition of Hepatitis B Virus Replication by APOBEC3G"
Rösler, C., Köck, J., Malim, M. H., Blum, H. E., & von Weizsäcker, F. (2004) · Science · doi:10.1126/science.1100464 · Cited by 78
Rose, K. M., Marin, M., Kozak, S. L., & Kabat, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406760200 · Cited by 78
Response to Comment on "Inhibition of Hepatitis B Virus Replication by APOBEC3G"
Turelli, P., Jost, S., Mangeat, B., & Trono, D. (2004) · Science · doi:10.1126/science.1101974 · Cited by 54
Cited by
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Lucifora, J., Xia, Y., Reisinger, F., Zhang, K., Stadler, D., Cheng, X., Sprinzl, M. F., Koppensteiner, H., Makowska, Z., Volz, T., et al. (2014) · Science · doi:10.1126/science.1243462 · Cited by 893
Harris, R. S., & Dudley, J. P. (2015) · Virology · doi:10.1016/j.virol.2015.03.012 · Cited by 551
Beck, J. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i1.48 · Cited by 494
Chiu, Y.-L., & Greene, W. C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090350 · Cited by 416
Metadata
- Authors
- Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain‐Hobson, S., Vartanian, J., & Greeve, J.
- Venue
- Hepatology
- Published
- 2006-06
- Volume
- 43
- Issue
- 6
- Pages
- 1364-1374
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2042304504
- Cited by
- 253
- References
- 45
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.